Drug Discovery Informatics Market Report 2023: R&D Consistency Drives Sector Growth

According to a recently published Drug Discovery Informatics Market analysis report by Future Market Insights, global sales of the Drug Discovery Informatics Market in 2022 were valued at US$ 2.9 billion. The market is expected to reach a valuation of US$ 12.5 billion by 2033, with a CAGR of 14.4% from 2023 to 2033. Discovery Informatics is forecast to be the most profitable segment, with a CAGR of more than 15% from 2023 to 2033.

According to the Drug Discovery Informatics Market research conducted by Future Market Insights, a market research and competitive intelligence provider, the market value of the Drug Discovery Informatics Market increased at a 12.8% CAGR from 2018 to 2022.

Precision medicine, which comprises improving the potency of medical care, is supported by Drug Discovery Informatics. It enhances the efficacy of Drug Discovery Informatics for specific patient groups using genetic or molecular profiling.

The emergence of cloud-based technologies and new analytics is a crucial element driving market expansion. Massive datasets can be stored, processed, and analysed at little cost thanks to cloud computing. Faster and better scientific research results from the usage of new computers and infrastructural technology.

Cloud computing gives the possibility to speed up basic research endeavours. Another important element expected to drive market expansion is pharmaceutical companies' increasing shift from traditional to data-driven technologies. The market for Drug Discovery Informatics, on the other hand, can be limited by high informatics software prices and setup expenses, as well as a scarcity of expert resources.

Competitive Landscape:

Some of the key companies in the drug discovery informatics market include Certara, Boehringer Ingelheim International GmbH, Infosys Ltd., Charles River Laboratories, Collaborative Drug Discovery, Inc., Eurofins DiscoverX Products, Jubilant Biosys, Selvita, Novo Informatics Pvt. Ltd., ChemAxon Ltd., Albany Molecular Research Inc., Oracle, Accenture, Agilent Technologies, Inc., and Illumina, Inc.

Read More@ https://www.futuremarketinsights.com/reports/drug-discovery-informatics-market

Market Segments Covered in Drug Discovery Informatics Market Analysis

By Technique:

  • Discovery Informatics
    • Identification, Validation, & Assay Development Informatics
    • Lead Generation
    • Enzymes
    • Other Cleanings
  • Development Informatics
    • Lead Optimization
    • FHD Preparation
    • Phase IA
    • Phase IB/2

By Mode:

  • Outsourced
  • In-house

By Services:

  • Sequence Analysis Platforms
  • Molecular Modelling
  • Docking
  • Clinical Trial Data Management
  • Other Services

Comments

Post a Comment

Popular posts from this blog

Empowering Diabetics | A Comprehensive Analysis of the Continuous Glucose Monitoring Device Market

Image
According to Future Market Insights' recently released Continuous Glucose Monitoring Device Market Analysis report, global sales of Continuous Glucose Monitoring Device Market in 2022 will be US$ 4.9 Billion. The market is expected to be valued US$ 16.8 billion by 2033, with a CAGR of 11.9% from 2023 to 2033. Market growth is predicted to be driven by an increase in the older population as well as a high prevalence of diabetes. The International Diabetes Federation predicts that the global diabetic population will reach 642 million by 2040. As a result, by 2040, one out of every 10 people would have diabetes, demonstrating the seriousness of the epidemic. Diabetes treatment and management are consequently projected to be a top priority for healthcare administrations and stakeholders around the world. Diabetes cases are predicted to increase, boosting market growth and the potential for continuous glucose monitoring systems, attracting and motivating various industry actors to prod...
Read more

Global Medical face shield Market Insights and Outlook 2022-2032

Image
Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights,  Medical Face Shields Market  will grow at over 11% CAGR through 2030. Medical face shields have proven to be an effective first-line defence against airborne diseases such as Zika, SARS, Ebola, flu, and now Covid-19. As a result, increased adoption of medical face shields, and thus increased production, is expected to drive the market during the forecast period. The IDSA (Infectious Diseases Society of America) has included the use of PPE (Personal Protective Equipment) such as face shields and masks in its recommendations. Though masks have been widely used throughout the world, their effectiveness is not widely known. The possibility of cloth masks providing marginal virus protection due to potential moisture retention, poor filtration, and re-use cannot be ruled out. Face ...
Read more

Cognitive Diagnostics Market Projected to Reach Unprecedented Growth by 2033

Image
As per Future Market Insights latest industry analysis, the valuation for the global  Cognitive Diagnostics market sales  is estimated to reach US$ 110.2 Billion in 2023 and is projected to exhibit a CAGR of 8.0% over the forecast period, with an estimated valuation of US$ 238.3 Billion by 2033. Several causes of brain problems or cognitive disorders include closed head injuries, contact with neurotoxins (toxic substances), genetics, infections, strokes, and tumours. Depending on the area of the brain that is impacted, a person may have a certain form of cognitive problem. Communication issues could result from, for instance, a tumour in the speech cisterns of the brain. In another illustration, a brain infection that affects the motor recentres would cause problems with movement. Ageing is also a factor in the development of cognitive problems. Cognitive diagnostics increasingly use digital health technologies like wearables and smartphone apps. These tools can monitor a pati...
Read more